Status:

COMPLETED

Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry

Lead Sponsor:

Universitair Ziekenhuis Brussel

Conditions:

Continuous Renal Replacement Therapy

CO2 Removal

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the present study is to assess the metabolic impact of Continuous Renal Replacement Therapy and overview the obstacles and important factors compromising the use of Indirect Calorimetry in ...

Detailed Description

Acute kidney injury (AKI) complicates a critical illness from 13% up to 78%, needing renal replacement therapy (RRT) up to10 % of all patients in the intensive care unit (ICU). Both intermittent (IRRT...

Eligibility Criteria

Inclusion

  • AKI requiring CRRT
  • Patient on CRRT who's filter you want to change
  • Expected stable patient during the test ( +- 2h) evaluated at discretion of physician :
  • No alteration in medication
  • Stable respiratory settings where no change in conditions is expected. If possible, controlled mode ventilation is preferred.
  • Expected stable pH and lactate
  • no intervention will be made on patient (transport/washing/physiotherapy/…)
  • no alterations on settings of CRRT is expected to be made.
  • Maximal respiratory settings: max FiO2: 60% / max inspiratory plateau pressure 30 mmHg/max tidal volumes 8ml/kg
  • pH between 7,30-7,50, lactate levels \<2,0
  • starting settings CRRT with citrate:
  • Blood pump flow: 150 ml/min
  • Predilution ( citrate): 1500-2300ml/h
  • Dialysate dose: 25-40 ml/kg/h
  • ultrafiltration: 0-300 ml /h
  • Substitution: NaCl 300-800 ml/h or B22: 400-2000 ml/h

Exclusion

  • Pregnancy / lactation
  • Contra-indications for the use of indirect calorimetry as stated by the AARC (FiO2\>60%, chest tubes)
  • Severe hemodynamic or ventilator instability.
  • CRRT modalities unusual to daily clinical ICU practice

Key Trial Info

Start Date :

April 26 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2019

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03314363

Start Date

April 26 2017

End Date

March 15 2019

Last Update

May 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

universitair ziekenhuis Brussel

Brussels, Belgium, 1090